Oncology partners, Parkinson’s partners, expanded European Commission, expanded FDA, and bacterial vaccines

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Scorpion & AstraZeneca
ABL & Sanofi
Vertex
Cochlear
Vaxcyte

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Devices with tech enablement, nano particles, Chinese approvals, and a massive series B for  biotechnology

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Stryker + Vocera
Merck KGaA + Exelead
BeiGene
Eikon

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

We’ve got a new name, gene therapy buyout, a lion of an approval, and an inescapable spotlight.

 
Find out more at
https://LifeScienceTodayPodcast.com

Story References
Novartis + Gyroscope
Leo
Biogen
Biogen 2

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Acquiring the acquired, EHR acquisition, first approvals, and a new fund for the new year

Originally Published as The Niche Podcast.

Find out more at
https://LifeScienceTodayPodcast.com

Story References
CSL + Vifor
Oracle + Cerner
Calliditas
Omega

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. You can expect highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Antitrust AI, development AI, expanded approval, mega seeds, and biosimilar SPACs

Originally Published as The Niche Podcast.

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Microsoft + Nuance
Roche + Recursion
Heron
1E
Alvotech 

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. You can expect highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Double acquisitions in Switzerland, FDA holds and what that means, CMV therapy, rare + oncology continues, BioCryst draws millions, and deer.

Originally Published as The Niche Podcast.

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Vifor + Sanifit + Inositec
Kura
Differential Syndrome
Takeda
Aadi
BioCryst
USDA

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. You can expect highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Top dollar lab notes, lab consolidation, RNA sells, and two new approval areas

Originally Published as The Niche Podcast.

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Benchling
Labcorp
Novo Nordisk
BioMarin
BioMarin 2
AppliedVR
AppliedVR 2

Music by Luke Goodson
https://www.soundcloud.com/lukegoodson

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. You can expect highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

A giant breaks in two, acquisitions in women’s health, Medicare cost, rare approvals, more CRISPR, and a legacy

Originally Published as The Niche Podcast.

Find out more at
https://LifeScienceTodayPodcast.com

Story References
Johnson & Johnson
Organon
Medicare
PharmaEssentia
Arbor Biotechnologies
Glen de Vries

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. You can expect highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

Roche and Novartis part ways, Alphabet likes AI, Pfizer 89%, Series A, B, and the money that gets you there

Originally Published as The Niche Podcast.

Find out more at
https://LifeScienceTodayPodcast.com


Story References
Roche - Novartis
Alphabet
Pfizer
Parthenon
Antios
Mission Bio
Section 32

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. You can expect highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.

This week, we have a special bonus interview with Danielle Coe, founder of Black Women in Clinical Research.

Danielle Coe
Black Women in Clinical Research

Originally Published as The Niche Podcast.

Find out more at
https://LifeScienceTodayPodcast.com

Background

Danielle Coe started her career as a lab-based scientist, after learning from a friend about work in clinical research she pivoted her goals. It wasn’t immediate, but she eventually found her way into the industry and has forged a path on the site side clinical research. Through the process she was struck by the lack of women of color. To help decrease this gap and drive diversity through peer-to-peer support, Danielle created Black Women in Clinical Research. The goal? To help other black women start and build careers in clinical research through community support, resume crafting, interview preparation, negation tactics for salary, and more.  

Danielle carved time out of her busy schedule to share her story. I really appreciate the way she has turned the challenges she faced into a solution for others and her drive to provide practical solutions, not just nice ideas.


About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. You can expect highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.